Back to Rheumatology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Rheumatoid Arthritis

Overview

Spherix’s coverage of the rheumatoid arthritis segment focuses on tracking brand usage and changes in the treatment paradigm with increasing interest in alternate mechanisms of action in the US and the EU5. We also provide detailed insights in patient characteristics that influence treatment switching decisions.

Services Available

Trending market evolution

  • Rheumatoid Arthritis (US) - quarterly, n=100

  • Rheumatoid Arthritis (EU) - semiannual, n=250

Exploring the patient journey

  • Biologic/Small Molecule Switching in RA (US) - n=1,000 patient charts

  • Biologic/Small Molecule Switching in RA (EU) - n=1,250 patient charts

Gauging impact of disruptive events

  • Multi-Specialty Impact of COVID-19 (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Rheumatoid Arthritis Coverage